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Summary 56 
 57 
Phylogeographic analyses identified 34 major international transmission events, starting in 58 
Europe around 1890, that resulted in the current distribution of E. coli O157:H7. These were 59 
likely facilitated by global cattle movements and will inform policy to reduce this pathogens 60 
spread. 61 
  62 
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Abstract  63 
 64 
Background. Shiga toxin-producing Escherchia coli O157:H7 is a zoonotic pathogen which 65 
causes numerous food and waterborne disease outbreaks. It is globally distributed but its origin 66 
and temporal sequence of geographical spread is unknown. 67 
 68 
Methods. We analysed Whole Genome Sequencing data of 757 isolates from 4 continents and 69 
performed a pan genome analysis to identify the core genome and from this extracted single 70 
nucleotide polymorphisms. Timed phylogeographic analysis was performed on a subset of the 71 
isolates to investigate it’s worldwide spread. 72 
 73 
Results. The common ancestor of this set of isolates occurred around 1890 (1845–1925) and 74 
originated from the Netherlands. Phylogeographic analysis identified 34 major transmission 75 
events. The earliest were predominantly intercontinental from Europe to Australia around 1937 76 
(1909-1958), to USA in 1941 (1921-1962), to Canada in 1960 (1943-1979), and from Australia 77 
to New Zealand in 1966 (1943-1982). This pre-dates the first reported human case of E. coli 78 
O157:H7 in 1975 from the USA. 79 
 80 
Conclusions.  Inter- and intra- continental transmission events have resulted in the current 81 
international distribution of E. coli O157:H7 and it is likely that these events were facilitated 82 
by animal movements (e.g. Holstein Friesian cattle). These findings will inform policy on 83 
action that is crucial to reduce further spread of E. coli O157:H7 and other (emerging) STEC 84 
strains globally.  85 
  86 
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 87 
Introduction 88 
 89 
Emerging infectious diseases (EIDs) are a significant and growing threat to global health, economy and 90 
security[1]. Most EIDs are driven by socio-economic, environmental and ecological factors[2]. 91 
Examples include the long-term spread and maintenance of cholera[3] and the (mis)use of 92 
antimicrobials resulting in the emergence of multi-drug resistant bacteria[4]. Agricultural 93 
intensification and/or environmental change have been associated with an increased risk of disease 94 
emergence, driven by the impact of an expanding human population and changing human interaction 95 
with the environment[5]. Animal trade has been identified as an underlying cause of the emergence and 96 
spread of infectious disease as exemplified by avian influenza[6] and swine flu[7]. Understanding 97 
emergence of disease is crucial in preventing such events in the future. 98 
 99 
Shiga toxin-producing Escherichia coli (STEC) are globally dispersed zoonotic pathogens associated 100 
with a broad spectrum of sequelae in humans, including diarrhoea, haemorrhagic colitis and 101 
(occasionally fatal) haemolytic uremic syndrome (HUS)[8]. Cattle and sheep are generally considered 102 
as the main reservoirs[9]. E. coli O157:H7 is the most commonly reported STEC serotype and was first 103 
recognised as a human pathogen in 1982 following two outbreaks associated with consumption of 104 
undercooked beef burgers in the USA[10]. It has since been reported on all continents except 105 
Antarctica[11] and transmission between countries has been hypothesised to be due to transport of 106 
livestock, and/or contaminated feed[12]. 107 
 108 
The current model of E. coli O157:H7 evolution suggests that the O serogroup conversion of an 109 
ancestral Stx2-producing E. coli O55 to O157 and subsequent loss of β-glucuronidase activity and 110 
sorbitol fermentation gave rise to the common ancestor of the current circulating population[13]. This 111 
population is divided into three major lineages (I, I/II and II) with a time to common ancestor of the 112 
current diversity estimated at 175 years ago[14]. Understanding the course of the global spread of E. 113 
coli O157 from its common ancestor may inform action to limit its further dissemination and future 114 
spread of other (emerging) foodborne pathogen including other STEC. 115 
 116 
Analysis of whole genome sequences (WGS) of E. coli O157:H7 can be used to identify a core genome 117 
(genes common to all strains in the analysis) and the accessory genome (genes present in at least one 118 
strain, but not all)[15]. Single nucleotide polymorphisms (SNPs) can then be obtained and used to 119 
generate timed phylogenies. The phylogenies obtained can be used subsequently to reconstruct a 120 
detailed history of the movement of pathogens at a range of spatial scales (e.g. within and between 121 
countries, as exemplified for Ebola[16] and swine flu[7]). 122 
 123 
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Here we conducted a spatio-temporal phylogenetic analysis of E. coli O157:H7 using the genomes of 124 
757 isolates originating from four continents. Firstly, a global core-genome phylogeny was produced 125 
to identify major clades followed by the reconstruction of a timed phylogeny using a representative 126 
subset of isolates. Secondly, the phylodynamic analysis were visualised on a global scale and compared 127 
with the history of reported cases of E. coli O157:H7 in different countries. 128 
 129 
Methods 130 
 131 
Sequenced isolates. Sequenced E. coli O157:H7 isolates(757) from Argentina(27), Australia(42), 132 
Canada(164), the Netherlands(63), New Zealand(151), Scotland(145), Sweden(45), USA(91) and other 133 
countries(29) were obtained along with associated metadata (Table S3). This sequence collection 134 
comprised isolates from the following sources: human clinical(401), cattle(233), sheep(29), food and/or 135 
environmental(79), and isolates of unknown origin(15). These data are available online (Table S3). 136 
 137 
Human E. coli O157:H7 incidence: These were obtained from the national reference laboratories for 138 
the above countries plus England and Wales and Japan (Table S1). A global cartogram visualising E. 139 
coli O157:H7 incidence was generated utilising a geoprocessing tool[17] available from 140 
http://www.arcgis.com/home/item.html?id=d348614c97264ae19b0311019a5f2276 and implemented 141 
in ArcMap 10.5. 142 
 143 
Analysis of genomes. 144 
 145 
(i) Pan-genomic SNP analysis: PANSEQ was used to construct a non-redundant pan-genome from all of 146 
the 757 genomes[15]. This involved using a seed genome and identifying regions of 500 base pairs (bp) 147 
in the seed and present in any other genome at a 99% sequence identity cut-off. Loci present in all 148 
genomes underwent multiple sequence alignment and were concatenated. This aligned  sequence was 149 
used to identify SNPs in the core genome of all isolates (Table S7). The very high sequence identity 150 
was selected to minimise the chances of recombinant regions being present in the core genome. A 151 
neighbour joining tree was generated in MEGA[18].  152 
 153 
(ii) Bayesian phylogeographic/phylodynamic analysis: BEAST (v1.8.2) inferred the spatiotemporal 154 
dynamics of E. coli O157[19]. The HKY nucleotide substitution model with “Gamma+Invariant sites”, 155 
with distributed rates among the sites was combined with the discrete trait substitution model (utilising 156 
Bayesian Stochastic Search Variable Selection). The runs were tested for a number of population 157 
models in combination with a log-normal relaxed clock for the time component and strict clock for the 158 
regional component of the trees. The temporal signal of the neighbour joining tree obtained from MEGA 159 
was investigated using TempEst v1.5 (http://tree.bio.ed.ac.uk/software/tempest/).  Ancestral state 160 
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reconstruction was performed at the country level. Computational times meant that not all isolates could 161 
be included in the analysis and a subset (n =197) were selected on the basis of representing the extent 162 
of international diversity from the phylogenetic tree generated in MEGA.  163 
 164 
The analyses were run for 100 million Markov Chain Monte Carlo (MCMC) steps and sampled every 165 
2,500 steps. Convergence of parameters was checked with TRACER (v1.5), using an effective sample 166 
size of 200 as the minimum to accept a model. Three independent runs were carried out to confirm 167 
convergence and these were combined with the LogCombiner (v1.8.2). TreeAnnotator was used to 168 
calculate the Maximum Clade Credibility Tree and the times to most recent common ancestor (MRCA) 169 
with a burn-in period of 10 million MCMC states (10%). The output trees were displayed in FigTree 170 
v1.4.3. 171 
 172 
Spread (v1.0.6) and SpreaD3 (v0.9.6) were used to dynamically display the phylogeographic 173 
information on Google Earth and Mozilla Firefox[20]. A major transmission event is defined as one 174 
where the geographical location of the common ancestor between two nodes has changed in the 175 
phylogeny. In contrast, a tip transmission event is defined as one where an isolate on the tip of the tree 176 
has been isolated from a different country than its MRCA (i.e. geographical change from node to tip). 177 
 178 
(iii) In silico PCR and probe-based assays were carried out both for backwards compatibility with 179 
previous studies and identification of known virulence markers (See Supplementary Information 180 
Section VII). This included: detection of E. coli O157:H7 antigen encoding, intimin and 181 
enterohemolysin genes; in silico Shiga toxin subtyping; LSPA6 sub-typing, tir 255T and 255A 182 
polymorphism analysis and Manning clade identification; SBI sub-typing and typing into Clades A-183 
G[21]. 184 
 185 
Results 186 
 187 
Recent incidence and recorded emergence of E. coli O157 188 
The recent incidences of E. coli O157:H7 infections (2010-2015) are presented in the format of a 189 
cartogram illustrating the relative importance of E. coli O157:H7 on a country by country basis (Fig. 190 
1). The first human cases of E. coli O157:H7 occurred in North America with a case of bloody diarrohea 191 
in the USA ( California) in 1975[22] and a case in Canada in 1979, but human cases were not recorded 192 
in South America (Argentina) until 1987 (Fig. 2 and Table S1). In Europe, serological evidence from 193 
human cases of HUS from the Netherlands date back to 1974. However, E. coli O157:H7 was not 194 
isolated from human cases in England and Wales until 1982, in Scotland in 1983, and in the Netherlands 195 
and Sweden in 1989 (Table S1). In Australia, it was reported during 1986 - 1988 and in New Zealand 196 
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in 1993. Where data were available, Fig. 2 shows the increase in reported cases following the first 197 
isolations. 198 
 199 
Generally, the first isolations of E. coli O157:H7 from cattle occurred after the initial reports of 200 
isolations in the same country from humans. An exception was Argentina, where E. coli O157:H7 was 201 
isolated from two calves in 1977, which is generally recognised as the first cattle isolates in the 202 
world[23]. 203 
 204 
Phylogeographic emergence of E. coli O157 205 
A neighbour joining tree (Fig. 3), containing all of the genomes from this study, readily demonstrates 206 
that representatives from individual countries exhibit distinct clustering. Genomes are clustered around 207 
the tree in seven clades labelled A to G. The relationship of these clades with previous DNA based 208 
typing systems for E. coli O157:H7 (provided in the supplementary material section VIII). Only the 209 
Netherlands is represented in all clades, while the USA is represented in all clades except Clade C. 210 
Argentina is present in the fewest clades (2), followed by New Zealand and Canada (3), and Australia 211 
(4). The tree was generated from 3956 SNPs obtained from the core genome (730kb). Both animal and 212 
human clinical isolates were dispersed across the tree except for Clade A which comprised eight clinical 213 
and two isolates from unknown sources (Fig. 3). 214 
 215 
TempEst demonstrated a poor correlation of genetic divergence through time. Hence, a relaxed, un-216 
correlated, log normally distributed clock (UCLD), as used previously for influenza A viruses in 217 
swine[7], was applied in BEAST, which enabled each branch of the tree to have its own evolutionary 218 
rate. The exponential growth and birth-death population models both converged and a Bayes factor 219 
(BF) of 4.28 provides positive support of the fit of the exponential growth model[24].  220 
 221 
The common ancestor of the isolates in this study using the exponential growth model was predicted 222 
(with a probability of 0.66) to have originated in the Netherlands around 1890 (Bayesian 95% credible 223 
interval 1845–1925) (Fig. 4). The birth-death model also found the Netherlands as the common ancestor 224 
around 1910 (1886-1932). The exponential growth model gives the second most probable ancestral 225 
origin as Scotland (probability 0.19), suggesting that Europe is the most likely origin for these isolates. 226 
The USA, Canada and Australia all showed relatively low probabilities of being the ancestral origin 227 
(0.06, 0.04 and 0.02, respectively). Clades A to E were predicted to have had a Dutch common ancestor 228 
from around 1905 (1870–1937), similar to the predicted date 1910 (1875–1940) for the separate 229 
common Dutch ancestor of Clades F and G. 230 
 231 
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The analysis predicts 34 main transmission events between countries (Table S2) of which 21 and 13 232 
were intra- and inter-continental, respectively. The earliest country to country transmissions were all 233 
intercontinental between the Netherlands and the following countries: Clade D to Australia in 1937 234 
(1909–1958), Clade G to the USA in 1941 (1927–1966) and Clade E(ii) to the USA in 1949 (1927–235 
1966) (Fig. 5 and Figures S1 and S2). Figure 5 shows that by 1985, less than ten years after the first 236 
reported case of E. coli O157:H7 in humans, the organism was present on at least four continents. The 237 
emergence of E. coli O157:H7 can be described in detail by individual country or by clade and this is 238 
provided in the supplementary material (Sections IV and V). 239 
 240 
Identification of virulent clades 241 
Virulent clades comprise E. coli O157:H7 isolates that have the ability to cause the most severe clinical 242 
disease (e.g. severe or bloody diarrhoea and HUS). There have been several reports indicating that stx2 243 
and in particular stx2a  and stx2d positive isolates exhibit greater morbidity than stx1 and other stx2 244 
isolates[25]. Of the 757 genomes in the present study, 476 (62.9%) harbour stx2a and none carry stx2d 245 
(Fig. 6). Clades F and G contain the highest proportion (>75%) of stx2a positive strains.  In contrast, 246 
Clades B, C, D and E, that dominate the lower branch of the BEAST phylogeny (Fig. 4), have very low 247 
carriage (<7%) of stx2a. This suggests that stx2a was not a characteristic of the common ancestor in this 248 
part of the phylogeny, but likely was introduced by stx2a carrying phage in more recent times. This can 249 
also be visualised by the distribution of SBI types in Fig. S1g. 250 
  251 
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Discussion 252 
This study provides the first comprehensive global phylogeographical analysis of Shiga toxin-253 
producing E. coli O157:H7. The common ancestor of the current circulating diversity  was estimated to 254 
have originated in the Netherlands (i.e. mainland Europe) around 1890 (1845–1925). This timeframe is 255 
very similar to a recent UK study on UK genomes,  of around 1840 (1817–1855)[26]. Although the 256 
earliest reported cases of human disease are from North America[22], a retrospective examination of 257 
sera from patients with HUS suggests an early presence (mid 1970s) of E. coli O157:H7 in the 258 
Netherlands[27]. However, the first reporting date of isolates from diseased humans within a region is 259 
dependent on several factors including: the presence of E. coli O157:H7 in a geographical area; its 260 
virulence (severity of clinical symptoms), the availability of detection methods, and the 261 
expertise/awareness of public health officials. 262 
 263 
Similar phylogeographic studies on infectious disease transmission have been performed (e.g. 264 
Ebola[16]) where person-to-person transmission is a key mechanism of spread. In contrast, E. coli 265 
O157:H7 has limited person-to-person transmission (most cases considered sporadic and only 10 -15% 266 
outbreak cases are secondary transmission[28]) and the global spread is more likely to be related to its 267 
epidemiology in animals. Long range animal movements have been found to play an important role in 268 
the global migration of swine flu[7]. There are several other ways E. coli O157:H7 can potentially be 269 
spread across large geographical distances[12]. First, contaminated animal feed has been reported for 270 
feedlot cattle in the mid-western USA[29] and feed can be exported or imported from overseas 271 
(http://www.food.gov.uk). Second, wild animals including birds can be relevant at regional or sub-272 
continental scales[30]. However, bird migration is unlikely to explain the longitudinal transmission 273 
routes since most bird migration occurs latitudinally. Third, international movement of other farm 274 
animals including pigs, goats and turkeys, which occasionally shed this pathogen[30]. Fourth, the global 275 
trade and transportation of contaminated food[26]. Since the chains of human infection are usually short 276 
it is more likely that this mechanism will result in tip transmissions. Altogether, animal movements, of 277 
cattle and sheep, are considered the most likely transmission pathway for E. coli O157:H7 to establish 278 
a long term presence in a country or region. 279 
 280 
The Netherlands being the origin of the current diversity of E. coli O157:H7 is plausible, as the country 281 
extensively exported Holstein-Friesian cattle across the world[31]. This German-Dutch breed, known 282 
for its high milk production, has been successfully introduced across the world where the climate and 283 
conditions are suited for European cattle, including North America (1850s), South America (1880s) and 284 
Japan (>100 years ago). There has been a long history of cattle movement between the USA and Canada, 285 
with approximately 500,000 animals crossing the border each year during the 1980s, which is 286 
contemporaneous with the predicted transmission events between these countries 287 
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(https://www.usitc.gov/publications/332/pub2591.pdf). Similarly, cattle and sheep imports into New 288 
Zealand from Australia and the UK have occurred since the 1860s and throughout the 20th century[32]. 289 
We were not able to quantitatively link the global spread of E. coli O157:H7 to the global cattle trade 290 
in the 19th and early 20th century as these historic data are incomplete but the importance of massive 291 
trans-atlantic cattle movements in the emergence and spread of O157 has been postulated 292 
previously[33]. 293 
 294 
The phylodynamic predictions infer the likely dates of introduction of E. coli O157:H7 into the 295 
countries under study were either before or about the same time as the first isolates were obtained from 296 
humans and/or cattle (Fig. 1 and Fig. 7). The Netherlands and Australia were the only countries where 297 
E. coli O157:H7 was predicted to be present >50 years before human case reports. However, for 298 
Australia, the first transmission wave (Clade D) carried generally the less potent Stx2c form of the Shiga 299 
toxin. Only with the second wave when stx2a Clade G strains were introduced around 1994, did it 300 
became likely that severe disease would occur, resulting in a greater need to investigate the aetiology 301 
of those cases. Since the Netherlands is predicted to harbour the common ancestor (1910 (1875–1940)) 302 
for the more virulent Clades F and G, which contain the stx2a gene, it would be expected that cases of 303 
severe disease associated with these pathogens would occur from this date onwards. Unfortunately, 304 
serological evidence only dates back to 1974[27], but it is likely that there were human cases prior to 305 
this. Alternatively, the prevalence in the cattle population may have been low at this time, resulting in 306 
minor or negligible disease rates in the human population. 307 
 308 
The main limitation of the present study is lack of representative genomes from a number of countries 309 
where E. coli O157:H7 is known to be present (e.g. elsewhere in Europe, Japan, China, Brazil, and the 310 
under-represented countries of the African continent). As a result, inferences in disease transmission in 311 
this paper must be considered in the context of such missing data, which may involve movement through 312 
intermediate countries[7]. The Netherlands being predicted as the origin of the current circulating 313 
diversity should be treated with some caution as it in fact may act as a proxy for central Europe. Finally, 314 
only a representative sub-set of all isolates could be used in the BEAST analysis due to computational 315 
requirements. 316 
 317 
Knowledge of the global spread of E. coli O157:H7 enables further insights into how to mitigate the 318 
effects of this pathogen and reduce the risk of future STEC emergence [34]. This study informs on how 319 
non-O157 STEC may spread globally in similar fashion as E. coli O157.  For biosecurity and trade 320 
purposes, movements of live animals are now recorded between a number of countries 321 
(http://comtrade.un.org) and it may be sensible to test animals for STEC prior to transport, as well as 322 
animal feed for any STEC prior to transportation/shipment. This would be particularly important when 323 
a new virulent strain of STEC has been detected in a country to prevent its further spread. General test 324 
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methods for detection and sequencing of E. coli O157:H7 and other STEC are available[35, 36]. and 325 
international collaboration will be critical here.  Furthermore, computer simulations of disease 326 
emergence and transmission would help identify countries at higher risk, and inform where surveillance 327 
and control strategies for animal movements should take place[7]. Additionally, promotion of trade in 328 
germplasm would also lessen the chance of transmission. 329 
In conclusion, if the measures mentioned above are not carried out, it is likely that new STEC strains 330 
will emerge and spread around the world and future generations will continue to suffer disease from 331 
this group of bacterial pathogens. 332 
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LEGENDS 378 
Figure 1. Cartogram of the incidence of E. coli O157:H7 per 10 million (per year) from 2010 – 2015 379 
where the area of the country corresponds to the incidence (Note Australia incidence is based on the 380 
years 2001-2009 which were the only available data), and insert is a map of the world of original scale 381 
with countries coloured black where data were available. 382 
 383 
Figure 2. The reported human cases of E. coli O157:H7 by country obtained from national reference 384 
laboratories (red arrow indicates first human case, green arrow first human case of HUS associated with 385 
E. coli O157:H7 and blue arrow first isolation from cattle). The horizontal coloured bars and filled dots 386 
represent the 95% credible intervals and most likely date of the first major introduction estimated by 387 
the BEAST analysis (there is no bar and dot for England/Wales and only the dot for Japan as there were 388 
0 and 1 genomes only from these countries in the current study). 389 
 390 
Figure 3. Nearest-neighbour joining tree of 757 E. coli O157:H7 isolates inferred from the 3956 SNP’s 391 
obtained from PANSEQ: Scotland ( ); Canada ( ); USA ( ); the Netherlands ( ); Sweden ( ); New 392 
Zealand ( ); Australia ( ); Europe ( ); Italy ( ); Egypt ( ); Asia ( ); Argentina ( ); South America 393 
( ); Unknown ( ). Letters indicate branches of Clades A to G. The scale marker indicates genetic 394 
distance in SNPs. The pie charts indicate proportion of a particular source in a clade (human clinical – 395 
( ); animal -( ); and other (food, environmental and unknown) -( )). The location of the root of the 396 
tree using an E. coli O55:H7 (strain CB9615) is highlighted [21].). 397 
 398 
Figure 4. Bayesian Maximum Clade Credibility (MCC) phylogeographic tree for 197 E. coli O157:H7 399 
isolates visualised by FigTree. Branch colours correspond to the most probable ancestral geographic 400 
location. Clades A–G are marked on the phylogeny. The dates of the transmission events are listed in 401 
Supplementary Table S2. The lower figure provides a demographic reconstruction of the population 402 
size using exponential growth rate. 403 
 404 
Figure 5. Geographic dynamics of the time to transmission of E. coli O157:H7. The arrows indicate 34 405 
major transmission events and dates are the median values of the MRCA taken from BEAST. The letters 406 
denote the phylogenetic clades (see Fig. 3). The map was based on the output from SpreaD3 and 407 
reconstructed in ArcMap 10.5. The map can be viewed dynamically in Google Earth using the kml file 408 
(Supplementary File S1.kml) or by video (Supplementary File S2.wmv see Fig. 7). 409 
 410 
Figure 6. Frequency of E. coli O157:H7 Shiga toxin genes by clade for (a) stx1a, (b) stx2a, (c) stx2c and 411 
(d) stx negative. 412 
 413 
Figure 7. Screenshot of video illustrating the global spread of E. coli O157:H7 414 
(Supplementary_File_S2.mp4). 415 
  416 
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Figure 2. The reported human cases of E. coli O157:H7 by country obtained from national reference 426 
laboratories (red arrow indicates first human case, green arrow first human case of HUS associated with 427 
E. coli O157:H7 and blue arrow first isolation from cattle). The horizontal coloured bars and filled dots 428 
represent the 95% credible intervals and most likely date of the first major introduction estimated by 429 
the BEAST analysis (there is no bar and dot for England/Wales and only the dot for Japan as there were 430 
0 and 1 genomes only from these countries in the current study).  431 
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 432 
 433 
Figure 3. Nearest-neighbour joining tree of 757 E. coli O157:H7 isolates inferred from the 3956 SNP’s 434 
obtained from PANSEQ: Scotland ( ); Canada ( ); USA ( ); the Netherlands ( ); Sweden ( ); New 435 
Zealand ( ); Australia ( ); Europe ( ); Italy ( ); Egypt ( ); Asia ( ); Argentina ( ); South America 436 
( ); Unknown ( ). Letters indicate branches of Clades A to G. The scale marker indicates genetic 437 
distance in SNPs. The pie charts indicate proportion of a particular source in a clade (human clinical – 438 
( ); animal -( ); and other (food, environmental and unknown) -( )). The location of the root of the 439 
tree using an E. coli O55:H7 (strain CB9615) is highlighted [21]. 440 
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 442 
Figure 4. Bayesian Maximum Clade Credibility (MCC) phylogeographic tree for 197 E. coli O157:H7 443 
isolates visualised by FigTree. Branch colours correspond to the most probable ancestral geographic 444 
location. Clades A–G are marked on the phylogeny. The dates of the transmission events are listed in 445 
Supplementary Table S2. The lower figure provides a demographic reconstruction of the population 446 
size using exponential growth rate. 447 
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 449 
 450 
Figure 5. Geographic dynamics of the transmission of E. coli O157:H7. The arrows indicate 34 major 451 
transmission events and dates are the median values of the MRCA taken from BEAST. The letters 452 
denote the phylogenetic clades (see Fig. 3). The map was based on the output from SpreaD3 and 453 
reconstructed in ArcMap 10.5. The map can be viewed dynamically in Google Earth using the kml file 454 
(Supplementary File S1.kml) or by video (Supplementary File S2.wmv and Fig. 7). 455 
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 457 
Figure 6. Frequency of E. coli O157:H7 Shiga toxin genes by clade for (a) stx1a, (b) stx2a, (c) stx2c and 458 
(d) stx negative. 459 
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 461 
 462 
Figure 7. Screenshot of video illustrating the global spread of E. coli O157:H7 463 
(Supplementary_File_S2.mp4). 464 
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